Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stock
Aristo Bio-Tech & Lifescience Limited is an agrochemical company focused on manufacturing and supplying pesticides and agrochemicals like insecticides, herbicides, fungicides, and plant growth regulators.
The company has expanded its operations beyond its primary state to Punjab and Uttar Pradesh, demonstrating a growing geographical reach.
In 2023, Aristo Bio-Tech raised Rs. 13.05 crore through a public issue, indicating strong investor confidence and a move towards expansion.
The company engages in contract manufacturing and job work services, positioning itself as a versatile player in the agrochemical market.
Industrial Manufacturing
Industrial Products
76 Cr
Low Risk
10.6
46.2
0.3
1.7
139.00
74.30
Sales CAGR
Profit CAGR
ROE
ROCE
Aristo Bio-Tech & Lifescience Ltd (ARISTO) is currently trading at N/A per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Aristo Bio-Tech & Lifescience Limited is an agrochemical company focused on manufacturing and supplying pesticides and agrochemicals like insecticides, herbicides, fungicides, and plant growth regulators. The company has expanded its operations beyond its primary state to Punjab and Uttar Pradesh, demonstrating a growing geographical reach. In 2023, Aristo Bio-Tech raised Rs. 13.05 crore through a public issue, indicating strong investor confidence and a move towards expansion. The company engages in contract manufacturing and job work services, positioning itself as a versatile player in the agrochemical market.
Over the past 52 weeks, Aristo Bio-Tech & Lifescience Ltd has traded between a low of ₹74.30 and a high of ₹139.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Aristo Bio-Tech & Lifescience Ltd has a market capitalization of approximately 76.25. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Aristo Bio-Tech & Lifescience Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 10.62 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 76.25 Cr, Aristo Bio-Tech & Lifescience Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Aristo Bio-Tech & Lifescience Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Aristo Bio-Tech & Lifescience Ltd is 10.62. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Bearish
0
Neutral
9
Bullish
5
Bearish
0
Neutral
17
Bullish
29
Bearish
0
Neutral
8
Bullish
24
Bearish
0
Neutral
9
Bullish
5
Bearish
0
Neutral
9
Bullish
5
Bearish
0
Neutral
8
Bullish
24
Bearish
0
Neutral
8
Bullish
24
Bearish
0
Neutral
8
Bullish
24
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
70.20 | 77 Cr | 10.27 | 1.12 | 0.00 | 10.91 | 14.05 | 6.88 | ||
164.10 | 77 Cr | 9.48 | 1.05 | 0.00 | 10.92 | 12.33 | 7.83 | ||
112.00 | 76 Cr | 10.62 | 1.71 | 0.54 | 16.14 | 17.00 | 4.63 | ||
63.71 | 71 Cr | 38.83 | 1.86 | 0.57 | 6.35 | 8.16 | 3.13 | ||
56.00 | 70 Cr | 75.04 | 0.72 | 0.00 | 1.82 | 3.21 | 0.59 | ||
114.40 | 68 Cr | 9.38 | 1.95 | 0.00 | 20.75 | 22.84 | 11.97 | ||
90.25 | 68 Cr | -50.51 | 10.66 | 0.00 | -20.68 | -20.12 | -21.07 | ||
| Median: 7 Co. | — | 90.25 | 71 Cr | 10.27 | 1.71 | 0.00 | 10.91 | 12.33 | 4.63 |
